Business Description
Dr. Martens PLC
ISIN : GB00BL6NGV24
Share Class Description:
CHIX:DOCSl: Ordinary SharesTotal Employee Number:
2,377Compare
Compare
Traded in other countries / regions
DOCS.UKDOCMF.USA3U2.Germany IPO Date
2021-02-04Description
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 1.09 | |||||
Debt-to-EBITDA | 3.08 | |||||
Interest Coverage | 2.27 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.03 | |||||
Beneish M-Score | -2.83 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.9 | |||||
3-Year EBITDA Growth Rate | -17.9 | |||||
3-Year EPS without NRI Growth Rate | -31.8 | |||||
3-Year FCF Growth Rate | 85.5 | |||||
3-Year Book Growth Rate | -2.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 20.74 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.39 | |||||
9-Day RSI | 45.27 | |||||
14-Day RSI | 49.26 | |||||
3-1 Month Momentum % | 9.94 | |||||
6-1 Month Momentum % | -8.6 | |||||
12-1 Month Momentum % | -7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.61 | |||||
Quick Ratio | 1.6 | |||||
Cash Ratio | 1.13 | |||||
Days Inventory | 257.53 | |||||
Days Sales Outstanding | 31.88 | |||||
Days Payable | 89.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.63 | |||||
Dividend Payout Ratio | 0.63 | |||||
3-Year Dividend Growth Rate | -23.5 | |||||
Forward Dividend Yield % | 3.63 | |||||
5-Year Yield-on-Cost % | 3.68 | |||||
3-Year Average Share Buyback Ratio | 1.5 | |||||
Shareholder Yield % | 9.36 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 66.15 | |||||
Operating Margin % | 7.88 | |||||
Net Margin % | 3.11 | |||||
EBITDA Margin % | 16.7 | |||||
FCF Margin % | 17.1 | |||||
OCF Margin % | 18.66 | |||||
ROE % | 6.75 | |||||
ROA % | 2.71 | |||||
ROIC % | 6.68 | |||||
3-Year ROIIC % | 106.17 | |||||
ROC (Joel Greenblatt) % | 18.33 | |||||
ROCE % | 8.34 | |||||
Years of Profitability over Past 10-Year | 8 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 28.76 | |||||
Forward PE Ratio | 13.59 | |||||
PE Ratio without NRI | 16.83 | |||||
Price-to-Owner-Earnings | 6.73 | |||||
PS Ratio | 0.88 | |||||
PB Ratio | 1.82 | |||||
Price-to-Tangible-Book | 7.02 | |||||
Price-to-Free-Cash-Flow | 5.09 | |||||
Price-to-Operating-Cash-Flow | 4.63 | |||||
EV-to-EBIT | 14.93 | |||||
EV-to-Forward-EBIT | 10.48 | |||||
EV-to-EBITDA | 6.94 | |||||
EV-to-Forward-EBITDA | 5.68 | |||||
EV-to-Revenue | 1.15 | |||||
EV-to-Forward-Revenue | 1.14 | |||||
EV-to-FCF | 6.75 | |||||
Price-to-GF-Value | 0.98 | |||||
Price-to-Projected-FCF | 0.46 | |||||
Price-to-Graham-Number | 2.26 | |||||
Earnings Yield (Greenblatt) % | 6.7 | |||||
FCF Yield % | 19.47 | |||||
Forward Rate of Return (Yacktman) % | 9.86 |
Dr. Martens PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dr. Martens PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-20 09:30 | In 149 days | ||
| Second quarter earnings results for 2027 | 2026-11-20 | In 148 days | ||
| GBP 0.017000 Cash Dividend | 2026-08-27 | In 63 days | ||
| General meeting for 2026 | 2026-07-15 08:30 | In 21 days | ||
| Fourth quarter earnings results for 2026 | 2026-06-05 | 0.71 (+0.57%) | ||
| Annual report for 2026 | 2026-06-02 | 0.73 (-0.27%) | ||
| Fourth quarter earnings results for 2026 | 2026-05-19 | 0.64 (+4.58%) | ||
| GBP 0.008500 Cash Dividend | 2026-03-05 | 0.66 (+0.53%) | ||
| Guidance call for 2026 | 2026-01-27 08:30 | 0.76 (+1.40%) | ||
| Second quarter earnings conference call for 2026 | 2025-11-28 09:00 | 0.77 (+1.45%) |
Show
Entries
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Dr. Martens PLC
No articles.